• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小肠细菌过度生长及其他肠道疾病

Small Intestinal Bacterial Overgrowth and Other Intestinal Disorders.

作者信息

Ghoshal Uday C, Ghoshal Ujjala

机构信息

Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226014, India.

Department of Microbiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226014, India.

出版信息

Gastroenterol Clin North Am. 2017 Mar;46(1):103-120. doi: 10.1016/j.gtc.2016.09.008.

DOI:10.1016/j.gtc.2016.09.008
PMID:28164845
Abstract

Gut microbiota is the largest organ of the human body. Although growth of bacteria more than 10 colony forming unit (CFU) per milliliter in culture of upper gut aspirate is used to diagnosis small intestinal bacterial overgrowth (SIBO), 10 CFU or more is being considered to suggest the diagnosis, particularly if colonic type bacteria are present in the upper gut. Although neither very sensitive nor specific, hydrogen breath tests are widely used to diagnose SIBO. Rifaximin is the best treatment for SIBO due to its broad spectrum, lack of systemic absorption, and safety profile.

摘要

肠道微生物群是人体最大的器官。虽然上消化道吸出物培养中每毫升细菌生长超过10个菌落形成单位(CFU)用于诊断小肠细菌过度生长(SIBO),但目前认为10 CFU或更多即提示诊断,尤其是当上消化道中存在结肠型细菌时。虽然氢呼气试验既不非常敏感也不特异,但它被广泛用于诊断SIBO。利福昔明因其广谱、无全身吸收及安全性等特点,是治疗SIBO的最佳药物。

相似文献

1
Small Intestinal Bacterial Overgrowth and Other Intestinal Disorders.小肠细菌过度生长及其他肠道疾病
Gastroenterol Clin North Am. 2017 Mar;46(1):103-120. doi: 10.1016/j.gtc.2016.09.008.
2
Evaluation of small intestinal bacterial overgrowth.小肠细菌过度生长的评估。
Expert Rev Gastroenterol Hepatol. 2023 May;17(5):461-467. doi: 10.1080/17474124.2023.2207008. Epub 2023 Apr 28.
3
A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth: a randomized, double-blind, placebo-controlled trial.一项概念验证研究表明,在伴有小肠细菌过度生长的肠易激综合征中,抗生素比在不伴有小肠细菌过度生长的肠易激综合征中更有效:一项随机、双盲、安慰剂对照试验。
Eur J Gastroenterol Hepatol. 2016 Mar;28(3):281-9. doi: 10.1097/MEG.0000000000000557.
4
Diagnosis of small intestinal bacterial overgrowth in the clinical practice.临床实践中小肠细菌过度生长的诊断
Eur Rev Med Pharmacol Sci. 2013;17 Suppl 2:30-5.
5
Characterization of Proximal Small Intestinal Microbiota in Patients With Suspected Small Intestinal Bacterial Overgrowth: A Cross-Sectional Study.疑似小肠细菌过度生长患者的近端小肠微生物组特征:一项横断面研究。
Clin Transl Gastroenterol. 2019 Aug;10(8):e00073. doi: 10.14309/ctg.0000000000000073.
6
Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome and its relationship with oro-cecal transit time.氢呼气试验在吸收不良综合征小肠细菌过度生长诊断中的应用及其与口盲肠转运时间的关系。
Indian J Gastroenterol. 2006 Jan-Feb;25(1):6-10.
7
Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture.与定量上消化道抽吸物培养相比,呼气试验在肠易激综合征患者小肠细菌过度生长诊断中的应用
Eur J Gastroenterol Hepatol. 2014 Jul;26(7):753-60. doi: 10.1097/MEG.0000000000000122.
8
Irritable bowel syndrome and small intestinal bacterial overgrowth: meaningful association or unnecessary hype.肠易激综合征与小肠细菌过度生长:是有意义的关联还是不必要的炒作。
World J Gastroenterol. 2014 Mar 14;20(10):2482-91. doi: 10.3748/wjg.v20.i10.2482.
9
Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth.临床试验:利福昔明联合部分水解瓜尔胶在根除小肠细菌过度生长方面比利福昔明单独使用更有效。
Aliment Pharmacol Ther. 2010 Oct;32(8):1000-6. doi: 10.1111/j.1365-2036.2010.04436.x. Epub 2010 Aug 18.
10
Small intestinal bacterial overgrowth: diagnosis and treatment.小肠细菌过度生长:诊断与治疗
Dig Dis. 2007;25(3):237-40. doi: 10.1159/000103892.

引用本文的文献

1
Fecal Coprococcus, hidden behind abdominal symptoms in patients with small intestinal bacterial overgrowth.粪便 Coprococcus,隐藏在小肠细菌过度生长患者的腹部症状背后。
J Transl Med. 2024 May 25;22(1):496. doi: 10.1186/s12967-024-05316-2.
2
Pediatric multiple sclerosis: an integrated outlook at the interplay between genetics, environment and brain-gut dysbiosis.小儿多发性硬化症:遗传学、环境与脑-肠微生物失调之间相互作用的综合观点
AIMS Neurosci. 2023 Aug 23;10(3):232-251. doi: 10.3934/Neuroscience.2023018. eCollection 2023.
3
Gender Influences Gut Microbiota among Patients with Irritable Bowel Syndrome.
性别对肠易激综合征患者的肠道微生物群有影响。
Int J Mol Sci. 2023 Jun 21;24(13):10424. doi: 10.3390/ijms241310424.
4
Clinical Presentation of Small Intestinal Bacterial Overgrowth from Aerodigestive Tract Bacteria Versus Colonic-Type Bacteria: A Comparison Study.经口-呼吸道细菌与结肠型细菌引起的小肠细菌过度生长的临床特征:一项对比研究。
Dig Dis Sci. 2023 Aug;68(8):3390-3399. doi: 10.1007/s10620-023-07999-x. Epub 2023 Jun 15.
5
Small Intestinal Bacterial Overgrowth and Non-Alcoholic Fatty Liver Disease: What Do We Know in 2023?小肠细菌过度生长与非酒精性脂肪性肝病:2023 年我们了解多少?
Nutrients. 2023 Mar 8;15(6):1323. doi: 10.3390/nu15061323.
6
Research trends in the field of the gut-brain interaction: Functional dyspepsia in the spotlight - An integrated bibliometric and science mapping approach.肠脑互动领域的研究趋势:聚焦功能性消化不良——一种综合文献计量学与科学图谱的方法
Front Neurosci. 2023 Mar 8;17:1109510. doi: 10.3389/fnins.2023.1109510. eCollection 2023.
7
Aetiology, diagnosis and management of small intestinal bacterial overgrowth.小肠细菌过度生长的病因、诊断与管理
Frontline Gastroenterol. 2022 Jul 12;14(2):149-154. doi: 10.1136/flgastro-2022-102163. eCollection 2023.
8
Short-term feeding of defatted bovine colostrum mitigates inflammation in the gut via changes in metabolites and microbiota in a chicken animal model.在鸡动物模型中,短期喂食脱脂牛初乳可通过代谢物和微生物群的变化减轻肠道炎症。
Anim Microbiome. 2023 Jan 26;5(1):6. doi: 10.1186/s42523-023-00225-z.
9
The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression.非酒精性肝病患者小肠细菌过度生长的患病率:NAFLD、NASH、纤维化、肝硬化-系统评价、荟萃分析和荟萃回归。
Nutrients. 2022 Dec 9;14(24):5261. doi: 10.3390/nu14245261.
10
Asian-Pacific consensus on small intestinal bacterial overgrowth in gastrointestinal disorders: An initiative of the Indian Neurogastroenterology and Motility Association.亚太地区胃肠疾病小肠细菌过度生长共识:印度神经胃肠病学和动力学会的倡议。
Indian J Gastroenterol. 2022 Oct;41(5):483-507. doi: 10.1007/s12664-022-01292-x. Epub 2022 Oct 10.